Ultra High Definition Endoscopy Market Analysis

Global Ultra-High-Definition Endoscopy Market Overview

The Ultra-High-Definition Endoscopy Market size was valued at USD 3.36 billion in 2022 and is projected to grow from USD 3.77 Billion in 2023 to USD 8.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.28% during the forecast period (2023 - 2030). Increasing demand for minimally invasive procedures and increasing prevalence of ultra-high-definition endoscopy for treatment and diagnosis are driving the market growth.

Global Ultra-High-Definition Endoscopy Market

• Increasing Demand for Minimally Invasive Procedures to Boost the Market Growth

The rising prevalence of chronic diseases such as gastrointestinal disorders and cancer of the mucosal lining has added to the increasing disease burden requiring endoscopic interventions. The rise in these diseases has assertively affected the adoption of endoscopy for therapeutic and diagnostic purposes. As per the recent reports from the American Cancer Society, there are over 26,380 new cases of stomach cancer observed in 2022, accounting for 1.5% of all cancers diagnosed. To diagnose the extent of the disease, practitioners undertake laparoscopic procedures. Laparoscopy is a minimally invasive procedure that allows a surgeon to view the inside of the abdomen and pelvis avoiding making major skin incisions.

The growing preference for minimally invasive procedures is fueled by technological advancements, high-quality therapy, shorter hospital stays, and easier recovery. Clinical practitioners use minimally invasive treatments to perform procedures that cause less damage to the patient. Moreover, the rise in the number of ambulatory surgical centers also adds to the increasing demand for minimally invasive procedures, further propelling the endoscopy market growth.

Ultra-High-Definition Endoscopy Market Segment Insights

Ultra-High-Definition Endoscopy Device Type Insights

The Market segmentation based on Ultra-High-Definition endoscopy device type, includes 4K ultra-high definition (UHD), and 8K ultra-high definition (UHD). The 4K ultra-high definition (UHD) segment held the majority share in 2022 in the Ultra-High-Definition Endoscopy Market revenue. This is due to the several advantages offered such as improved visibility, precision, and safer surgery, along with four times more information than conventional Full HD imaging systems. In addition, it also improves magnification and operability with a large screen and electronic zoom.

April 2020: Olympus Corporation (Japan) launched the EVIS X1 4k ultra-high-definition endoscopy system for the diagnosis and screening of disorders of the stomach, colon, and esophagus, as well as from bronchial diseases

January 2020: Pentax Medical (Japan) launched the IMAGINA 4k Endoscopy System in the US market is ideal for gastrointestinal procedures in ambulatory surgical centers

Ultra-High-Definition Endoscopy Application Insights

The Market segmentation of Ultra-High-Definition Endoscopy based on applications includes arthroscopy, laparoscopy, GI endoscopy, obstetrics/gynecology, ENT endoscopy, pulmonary endoscopy, and others. The laparoscopy segment dominated the market in 2022 with respect to the market revenue of ultra-high-definition endoscopy. This is owing to the rise in laparoscopic procedures and technological advancements in ultra-high-definition endoscopy. Technologically advanced endoscopes play an important role and can be used for the early detection of diseases and help in early diagnosis and treatment. Advanced laparoscope devices assist in cancer or other abnormality detection, and several other breakthroughs thereby improving the procedure results and success rates. Moreover, the increasing prevalence of diseases such as cancers, requiring laparoscopic interventions, contributes to the rising adoption of the procedure.   

As per the epidemiology study cited in the National Center for Biotechnology Information (NCBI), gastric cancer is deemed 5th most common form of cancers with high mortality rate and caused over 783,000 deaths in 2020. Thus, with rising disease prevalence and technological advancement in endoscopic procedures, the market is anticipated to grow exponentially in the foreseeable future.

September 2020: Pentax Medical (Japan) announced the launch of its innovative UHD J10 series of ultrasound video gastroscopes. This technologically advanced gastroscope with ergonomic design, enhanced maneuverability, and better image quality will be beneficial in delivering both market and clinical needs.

Ultra-High-Definition Endoscopy End User Insights

The Market segments of Ultra-High-Definition Endoscopy based on end-user includes hospitals, ambulatory surgical centers, and others. The hospital held the largest market share in 2022 in respect to the Ultra-High-Definition Endoscopy Market revenue. This is owing to the hospitals using more sophisticated ultra-high-definition endoscopic techniques, that are expected to boost patient preference for hospitals. The market will rise further because of an increase in hospital admissions for gastrointestinal diseases, cancer, and other chronic ailments. Other factors that are favorably influencing the expansion of the hospital segment include the rise in disease screening tests and the accessibility of highly skilled healthcare workers. Furthermore, it is projected that the segment growth will be favorably impacted by the robust healthcare infrastructure and rising patient awareness. Additionally, the incidence of cancer, infections, and metabolic diseases among the aging population will increase the rate of hospital diagnosis and treatment.

December 2019: Boston Scientific (US) received FDA approval for its EXALT Model D 4k Single-Use Duodenoscope that finds application in endoscopic retrograde cholangiopancreatography (ERCP) procedures

Figure 2: Ultra-High-Definition Endoscopy Market, by End User, 2022 & 2030 (USD Billion)Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Ultra-High-Definition Endoscopy Regional Insights

By Region, the study segments the market into North America, Europe, Asia-Pacific and Rest of the World. North America ultra-high-definition endoscopy held the largest market share in 2022. This is attributed to the growing adoption of elective ultra-high-definition endoscopic procedures, improved healthcare expenditure, and the increasing geriatric population. Further, the major countries studied are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: GLOBAL ULTRA-HIGH-DEFINITION MARKET SIZE BY REGION 2022 & 2030Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe ultra-high-definition endoscopy market accounts for the second-largest market share due to the rising prevalence of chronic disorders, and growing awareness of early detection of diseases through minimally invasive surgical procedures. Further, the Germany market of ultra-high-definition endoscopy held the largest market share, and the France market of ultra-high-definition endoscopy was the fastest growing market in the European region.

The Asia-Pacific ultra-high-definition endoscopy market is expected to grow at a significant growth rate during the forecast period. This is due to the presence of a large patient population suffering from functional gastrointestinal disorders and other chronic diseases. Some of the other factors contributing to the growth of the Asia-Pacific regional market include the growing geriatric population and improving healthcare infrastructure. In addition, rapid economic development and increasing government healthcare investments are projected to attract foreign investments in this region. Moreover, China endoscopy market held the largest market share, and the India market of ultra-high-definition endoscopy was the fastest growing market in the Asia-Pacific region. Hence, Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2023–2030.

Ultra-High-Definition Endoscopy Key Market Players & Competitive Insights

Major market players are spending a lot of capital on R&D to increase their product lines, which will help the market of ultra-high-definition endoscopy grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the ultra-high-definition endoscopy industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment. One of the primary business strategies adopted by manufacturers in the global ultra-high-definition endoscopy industry is to manufacture locally to reduce operating costs.

Fujifilm Holdings Corporation (Japan) is one of the key players operating in the market. It develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment. The company's business innovation segment provides devices and services used in offices, including multi-function devices and printers; and provides problem-solving document services tailored to diverse business formats and roles, including system integration, cloud service, business process outsourcing, and others. In August 2021, Fujifilm Holdings Corporation announced the launch of the 4k UHD ELUXEO 7000X System, a novel video imaging technology. This advanced imaging system is beneficial in enabling real-time visualization of the hemoglobin-oxygen saturation levels in the tissues during endoluminal imaging and laparoscopic procedures.

Key Companies in the Ultra-High-Definition Endoscopy Market Include

• Olympus Corp. (Japan)


• PENTAX Medical (Japan)


• Ethicon US, LLC (US)


• Fujifilm Holdings Corp. (Japan)


• Stryker (US)


• Boston Scientific Corp. (US)


• CONMED Corp. (US)


• Karl Storz GmbH & Co., KG (Germany)


• Richard Wolf Medical Instruments (US)


• Medtronic (Ireland)

Ultra-High-Definition Endoscopy Industry Developments

In October 2022: Carl Zeiss Ag (Germany) received FDA approval for 4k UHD MTLawton, disposable bipolar forceps made from copper-base alloy that potentially reduces tissue adhesion and subsequent charring during dissection of tissue

June 2021: Smith & Nephew Plc (UK) launched a 8k UHD robot-assisted endoscope, a Real Intelligence Suite of enabling technology solutions, which includes the next-generation robotics platform and the CORI Surgical System

May 2021: EndoFresh (China) received FDA clearance for the 8k UHD Disposable Digestive Endoscopy System to diagnose and treat gastrointestinal disorders

Ultra-High-Definition Endoscopy Market Segmentation

Ultra-High-Definition Endoscopy Device Type Outlook

• 4K ultra-high definition (UHD)


• 8K ultra-high definition (UHD)

Ultra-High-Definition Endoscopy Application Outlook

• Arthroscopy


• Laparoscopy


• GI Endoscopy


• Obstetrics/Gynecology


• ENT Endoscopy


• Pulmonary Endoscopy


• Others

Ultra-High-Definition Endoscopy End-User Outlook

• 
  

  Hospitals

  
  


• 
  

  Ambulatory Surgical Centers

  
  


• 
  

  Others

  
  

Ultra-High-Definition Endoscopy Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America